AACR 2024 San Diego，APR 5th 有意思的topic走起来

[Tlexander]

2:35 PM - 2:45 PM CT037 - A phase I investigator-initiated trial of evorpacept (ALX148), lenalidomide and rituximab for patients with relapsed or refractory B-cell non-Hodgkin lymphoma
2:50 PM - 3:00 PM CT038 - Preliminary efficacy and safety results of anti-TROP2 ADC SKB264 (MK-2870) in patients (pts) with previously treated advanced gastric (G) or gastroesophageal junction (GEJ) cancer from a Phase 2 study
3:05 PM - 3:15 PM CT039 - Alectinib in children and adolescents with solid or CNS tumors harboring ALK-fusions: Data from the iMATRIX Alectinib Phase I/II open-label, multi-center study
3:20 PM - 3:30 PM CT040 - First-in-human dose-expansion study of NBF-006, a novel investigational siRNA targeting GSTP, in patients with KRAS-mutated non-small cell lung cancer
3:35 PM - 3:45 PM CT042 - NCI10217: Phase Ib biomarker-driven tumor-agnostic combination (Combo) trial of copanlisib (Copa) and olaparib (Ola) in molecularly-selected patients (pts) with advanced cancers with PIK3CA hotspot, PTEN and DNA damage response (DDR) mutations
3:50 PM - 4:00 PM CT044 - A phase 0/1b study of AZD1390 plus radiotherapy in newly-diagnosed, MGMT-unmethylated glioblastoma patients
4:00 PM - 4:10 PM CT043 - Safety and preliminary efficacy of AZD1390 + radiation therapy (RT) for glioblastoma (GBM)

[Tlexander]

https://www.abstractsonline.com/pp8/#!/ ... ession/665

[Tlexander]

AACR2024@San Diego的Abstract全部出来了，谁有空来写个爬虫把abstract title整理一下：https://www.abstractsonline.com/pp8/#!/ ... ot=Apr05/1 ？